Skip to main content

MoneyWorks4Me

Cadila Healthcare submits press release

16 May 2020 Evaluate

Cadila Healthcare has informed that the Company enclosed a Press Release dated May 16, 2020 titled ‘Zydus Cadila receives tentative approval from USFDA for Droxidopa Capsules, 100 mg, 200 mg, and 300 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..